Cardiff Oncology (NASDAQ:CRDF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cardiff Oncology (CRDF) operate in?

Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cardiff Oncology Stock (NASDAQ: CRDF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	1.38K / 1.90M
Day Range	- - -
52 Wk Range	1.41 - 6.42
Market Cap	$279.40M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	66
Short Interest	15.24%
Days to Cover	1.48

Recent News

US Small Business Optimism Hits 3-Year High As Election Results 'Signal A Major Shift'

Small businesses are entering the holiday season with newfound confidence and momentum, thanks to post-election policies and reduced inflation.

Piero Cingari

What's Going On With Cardiff Oncology Stock On Tuesday?

Cardiff Oncology's CRDF-004 trial shows promising onvansertib results in RAS-mutated mCRC patients, with higher tumor response rates and a strong safety profile.

Vandana Singh

Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to 39,007.30 while the NASDAQ fell 0.18% to 16,245.77. The S&P 500 also fell, dropping, 0.01% to 5,137.05.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	1.38K / 1.90M
Day Range	- - -
52 Wk Range	1.41 - 6.42
Market Cap	$279.40M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	66
Short Interest	15.24%
Days to Cover	1.48

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cardiff Oncology (CRDF) stock?

You can purchase shares of Cardiff Oncology (NASDAQ:CRDF) through any online brokerage.

View our list of the best stock brokerages

Who are Cardiff Oncology (CRDF) competitors?

Other companies in Cardiff Oncology’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Larimar Therapeutics (NASDAQ:LRMR) and Eledon Pharma (NASDAQ:ELDN).

What is the forecast, or price target, for Cardiff Oncology (CRDF) stock?

Cardiff Oncology has a consensus price target of $9.25.

What is the current price for Cardiff Oncology (CRDF)?

The stock price for Cardiff Oncology (NASDAQ: CRDF) is $4.2 last updated December 26, 2024 at 6:38 AM EST.

Does Cardiff Oncology (CRDF) pay a dividend?

There are no upcoming dividends for Cardiff Oncology.

When is Cardiff Oncology (NASDAQ:CRDF) reporting earnings?

Cardiff Oncology’s Q4 earnings are confirmed for Thursday, February 27, 2025.

Is Cardiff Oncology (CRDF) going to split?

There is no upcoming split for Cardiff Oncology.

What sector and industry does Cardiff Oncology (CRDF) operate in?

Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Cardiff Oncology

Cardiff Oncology (CRDF) Forecast